My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 156

    1.

    Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.

    Castellani LW, Goto AM, Lusis AJ.

    Diabetes. 2001 Mar;50(3):643-51.PMID: 11246886 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.

    Hazel M, Cooksey RC, Jones D, Parker G, Neidigh JL, Witherbee B, Gulve EA, McClain DA.

    Endocrinology. 2004 May;145(5):2118-28. Epub 2003 Dec 18.PMID: 14684615 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II.

    Castellani LW, Gargalovic P, Febbraio M, Charugundla S, Jien ML, Lusis AJ.

    J Lipid Res. 2004 Dec;45(12):2377-87. Epub 2004 Oct 1.PMID: 15466364 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.

    Marzal-Casacuberta A, Blanco-Vaca F, Ishida BY, Julve-Gil J, Shen J, Calvet-Márquez S, González-Sastre F, Chan L.

    J Biol Chem. 1996 Mar 22;271(12):6720-8.PMID: 8636092 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.

    Carvalho E, Kotani K, Peroni OD, Kahn BB.

    Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E551-61. Epub 2005 May 31.PMID: 15928024 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.

    Moller DE, Chang PY, Yaspelkis BB 3rd, Flier JS, Wallberg-Henriksson H, Ivy JL.

    Endocrinology. 1996 Jun;137(6):2397-405.PMID: 8641192 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.

    Julve J, Escolà-Gil JC, Marzal-Casacuberta A, Ordóñez-Llanos J, González-Sastre F, Blanco-Vaca F.

    Biochim Biophys Acta. 2000 Nov 15;1488(3):233-44.PMID: 11082533 [PubMed - indexed for MEDLINE]Related articles

    8.

    Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

    Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ.

    Science. 1993 Jul 23;261(5120):469-72. Erratum in: Science 1993 Oct 8;262(5131):164. PMID: 8332912 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.

    Koopmans SJ, Jong MC, Que I, Dahlmans VE, Pijl H, Radder JK, Frölich M, Havekes LM.

    Diabetologia. 2001 Apr;44(4):437-43.PMID: 11357474 [PubMed - indexed for MEDLINE]Related articles

    10.

    Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.

    Blanco-Vaca F, Escolà-Gil JC, Martín-Campos JM, Julve J.

    J Lipid Res. 2001 Nov;42(11):1727-39. Review.PMID: 11714842 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity.

    Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M, Kersten S.

    J Biol Chem. 2006 Jan 13;281(2):934-44. Epub 2005 Nov 4. Erratum in: J Biol Chem. 2006 Jul 28;281(30):21575. PMID: 16272564 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose.

    Sauvaget D, Chauffeton V, Dugué-Pujol S, Kalopissis AD, Guillet-Deniau I, Foufelle F, Chambaz J, Leturque A, Cardot P, Ribeiro A.

    Diabetes. 2004 Mar;53(3):672-8.PMID: 14988251 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.

    Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.

    Circ Res. 2004 Oct 15;95(8):789-97. Epub 2004 Sep 23.PMID: 15388641 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.

    Castellani LW, Nguyen CN, Charugundla S, Weinstein MM, Doan CX, Blaner WS, Wongsiriroj N, Lusis AJ.

    J Biol Chem. 2008 Apr 25;283(17):11633-44. Epub 2007 Dec 26.PMID: 18160395 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.

    Hedrick CC, Castellani LW, Warden CH, Puppione DL, Lusis AJ.

    J Biol Chem. 1993 Sep 25;268(27):20676-82.PMID: 8376417 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.

    Weng W, Brandenburg NA, Zhong S, Halkias J, Wu L, Jiang XC, Tall A, Breslow JL.

    J Lipid Res. 1999 Jun;40(6):1064-70.PMID: 10357838 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin.

    Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R, Abumrad NA.

    J Biol Chem. 1999 Sep 17;274(38):26761-6.PMID: 10480880 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility.

    Martín-Campos JM, Escolà-Gil JC, Ribas V, Blanco-Vaca F.

    Curr Opin Lipidol. 2004 Jun;15(3):247-53. Review.PMID: 15166779 [PubMed - indexed for MEDLINE]Related articles

    19.

    Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.

    Allayee H, Castellani LW, Cantor RM, de Bruin TW, Lusis AJ.

    Circ Res. 2003 Jun 13;92(11):1262-7. Epub 2003 May 8.PMID: 12738753 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.

    Norris AW, Chen L, Fisher SJ, Szanto I, Ristow M, Jozsi AC, Hirshman MF, Rosen ED, Goodyear LJ, Gonzalez FJ, Spiegelman BM, Kahn CR.

    J Clin Invest. 2003 Aug;112(4):608-18.PMID: 12925701 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity